Ephrin-B stimulation of calvarial bone formation

Developmental Dynamics

Volumn 241, Issue 12, 2012, Pages 1901-1910

  Benson, M Douglas ^a   Opperman, Lynne A ^a   Westerlund, Jan ^a   Fernandez, Claudia R ^a   San Miguel, Symone ^a   Henkemeyer, Mark ^b   Chenaux, George ^b  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bone; Calvaria; Ephrin B; Osteoblast

Indexed keywords

COLLAGEN TYPE 1; EPHRIN B1; EPHRIN B2;

ALLELE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; DURA MATER; GENE EXPRESSION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELL LINE; EPHRIN-B2; IMMUNOGLOBULIN FC FRAGMENTS; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; OSTEOBLASTS; OSTEOGENESIS; RECEPTOR, EPHB1; RECEPTOR, EPHB2; RECOMBINANT FUSION PROTEINS; SKULL;

MUS;

EID: 84869814667     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.23874     Document Type: Article

References (50)

1. Arthur A, Koblar S, Shi S, Gronthos S. 2009. Eph/ephrinB mediate dental pulp stem cell mobilization and function. J Dent Res 88: 829-834.
2. Bellows CG, Aubin JE. 1989. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev Biol 133: 8-13.
3. Bellows CG, Aubin JE, Heersche JN, Antosz ME. 1986. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38: 143-154.
4. Benson MD, Aubin JE, Xiao G, Thomas PE, Franceschi RT. 1999. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J Bone Miner Res 14: 396-405.
5. Benson MD, Bargeon JL, Xiao G, Thomas PE, Kim A, Cui Y, Franceschi RT. 2000. Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast-selective expression. J Biol Chem 275: 13907-13917.
6. Bush JO, Soriano P. 2010. Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries. Genes Dev 24: 2068-2080.
7. Chenaux G, Henkemeyer M. 2011. Forward signaling by EphB1/EphB2 interacting with ephrin-B ligands at the optic chiasm is required to form the ipsilateral projection. Eur J Neurosci 34: 1620-1633.
8. Davy A, Aubin J, Soriano P. 2004. Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18: 572-583.
9. Davy A, Bush JO, Soriano P. 2006. Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol 4: e315.
10. Dravis C, Yokoyama N, Chumley MJ, Cowan CA, Silvany RE, Shay J, Baker LA, Henkemeyer M. 2004. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol 271: 272-290.
11. Franceschi RT, Ge C, Xiao G, ROCA H, Jiang D. 2007. Transcriptional regulation of osteoblasts. Ann NY Acad Sci 1116: 196-207.
12. Genander M, Frisén J. 2010. Ephrins and Eph receptors in stem cells and cancer. Curr Opin Cell Biol 22: 611-616.
13. Gerety SS, Wang HU, Chen ZF, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4: 403-414.
14. Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T, Klein R. 1996. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86: 35-46.
15. Holmberg J, Genander M, Halford MM, Annerén C, Sondell M, Chumley MJ, Silvany RE, Henkemeyer M, Frisén J. 2006. EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 125: 1151-1163.
16. Hughes F, Turner W, Belibasakis G, Martuscelli G. 2006. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 41: 48-72.
17. Irie N, Takada Y, Watanabe Y, Matsuzaki Y, Naruse C, Asano M, Iwakura Y, Suda T, Matsuo K. 2009. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem 284: 14637-14644.
18. Karsenty G, Wagner EF. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406.
19. Klein R. 2009. Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nature Neurosci 12: 15-20.
20. Knöll B, Weinl C, Nordheim A, Bonhoeffer F. 2007. Stripe assay to examine axonal guidance and cell migration. Nature Prot 2: 1216-1224.
21. Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, Weber PB, Feng JQ, Bonewald LF, Kneissel M. 2010. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 30: 3071-3085.
22. Kullander K, Klein R. 2002. Mechanisms and functions of Eph and ephrin signalling. Nature Rev Mol Cell Biol 3: 475-486.
23. Lim Y-S, McLaughlin T, Sung T-C, Santiago A, Lee K-F, O'Leary DDM. 2008. p75(NTR) mediates ephrin-A reverse signaling required for axon repulsion and mapping. Neuron 59: 746-758.
24. Martin TJ, Allan EH, Ho PWM, Gooi JH, Quinn JMW, Gillespie MT, Krasnoperov V, Sims NA. 2010. Communication between ephrinB2 and EphB4 within the osteoblast lineage. Adv Exp Med Biol 658: 51-60.
25. Maruyama T, Mirando AJ, Deng C-X, Hsu W. 2010. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal 3: ra40.
26. Matsuo K. 2010. Eph and ephrin interactions in bone. Adv Exp Med Biol 658: 95-103.
27. McCauley LK, Martin TJ. 2012. Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res 27: 1231-1239.
28. Medici D, Olsen BR. 2011. Transforming blood vessels into bone. Cell Cycle 10: 362-363.
29. Medici D, Olsen BR. 2012. The role of endothelial-mesenchymal transition in heterotopic ossification. J Bone Miner Res 27: 1619-1622.
30. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. 2010. Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Med 16: 1400-1406.
31. Merrill AE, Bochukova EG, Brugger SM, Ishii M, Pilz DT, Wall SA, Lyons KM, Wilkie AOM, Maxson RE. 2006. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Human Mol Genet 15: 1319-1328.
32. Mirando AJ, Maruyama T, Fu J, Yu H-MI, Hsu W. 2010 β-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis. BMC Dev Biol 10: 116.
33. Murai KK, Pasquale EB. 2003. 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci 116: 2823-2832.
34. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H. 2011. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nature Med 17: 1231-1234.
35. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC. 1995. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10: 1978-1987.
36. Opperman LA, Fernandez CR, So S, Rawlins JT. 2006. Erk1/2 signaling is required for Tgf-beta 2-induced suture closure. Dev Dyn 235: 1292-1299.
37. Pasquale EB. 2004. Eph-ephrin promiscuity is now crystal clear. Nature Neurosci 7: 417-418.
38. Rawlins JT, Opperman LA. 2008. Tgf-beta regulation of suture morphogenesis and growth. Front Oral Biol 12: 178-196.
39. Risley M, Garrod D, Henkemeyer M, McLean W. 2009. EphB2 and EphB3 forward signalling are required for palate development. Mech Dev 126: 230-239.
40. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science (NY) 289: 1508-1514.
41. San Miguel S, Serrano MJ, Sachar A, Henkemeyer M, Svoboda KKH, Benson MD. 2011. Ephrin reverse signaling controls palate fusion via a PI3 kinase-dependent mechanism. Dev Dyn 240: 357-364.
42. Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP. 2011. Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest 34: 801-810.
43. Twigg SRF, Kan R, Babbs C, Bochukova EG, Robertson SP, Wall SA, Morriss-Kay GM, Wilkie AOM. 2004. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci USA 101: 8652-8657.
44. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. 1999. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14: 893-903.
45. Wieland I, Reardon W, Jakubiczka S, Franco B, Kress W, Vincent-Delorme C, Thierry P, Edwards M, König R, Rusu C, Schweiger S, Thompson E, Tinschert S, Stewart F, Wieacker P. 2005. Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS). Human Mutat 26: 113-118.
46. Williams SE, Mann F, Erskine L, Sakurai T, Wei S, Rossi DJ, Gale NW, Holt CE, Mason CA, Henkemeyer M. 2003. Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. Neuron 39: 919-935.
47. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. 1998. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 273: 32988-32994.
48. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. 2000. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275: 4453-4459.
49. Xing W, Kim J, Wergedal J, Chen S-T, Mohan S. 2010. Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1. Mol Cell Biol 30: 711-721.
50. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K. 2006. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4: 111-121.